Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Labcorp Holdings ( (LH) ) just unveiled an update.
Labcorp Holdings Inc. announced on September 25, 2025, that it will release its third-quarter financial results for 2025 on October 28, 2025, before the market opens. The company will host a conference call and webcast to discuss these results, with the webcast available on the Labcorp Investor Relations website. A replay of the webcast will be accessible until October 15, 2026.
The most recent analyst rating on (LH) stock is a Buy with a $311.00 price target. To see the full list of analyst forecasts on Labcorp Holdings stock, see the LH Stock Forecast page.
Spark’s Take on LH Stock
According to Spark, TipRanks’ AI Analyst, LH is a Outperform.
Labcorp Holdings demonstrates strong financial management and positive technical indicators, contributing to a favorable outlook. The company’s robust earnings call and strategic initiatives further enhance its position. However, high valuation metrics and potential regulatory risks temper the overall score.
To see Spark’s full report on LH stock, click here.
More about Labcorp Holdings
Labcorp Holdings Inc. is a global leader in innovative and comprehensive laboratory services, providing diagnostics and drug development capabilities. The company supports doctors, hospitals, pharmaceutical companies, researchers, and patients in making informed decisions, and is involved in the approval of new drugs and therapeutic products. Labcorp operates in approximately 100 countries with nearly 70,000 employees, conducting over 700 million tests annually.
Average Trading Volume: 630,742
Technical Sentiment Signal: Buy
Current Market Cap: $23.21B
Find detailed analytics on LH stock on TipRanks’ Stock Analysis page.